Advertisement
Qiagen N.V.

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.โ€™s financial performance, market position, analyst ratings, and future outlook.

QGENโ—NYSE
HealthcareMedical - Diagnostics & Research
$37.14
$0.91(2.51%)
U.S. Market is Open ยท 14:39
Advertisement

Qiagen N.V. (QGEN)

Meyka AI Score

Z

Key Financials

Market Cap7.8B
P/E Ratio19.33
EPS (TTM)$1.96
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$44.90
3 Months$50.63
1 Year Target$49.23

QGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qiagen N.V. (QGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.52, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.33 and a market capitalization of 7.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.22%
5-Day Change
2.03%
1-Month Change
14.29%
3-Month Change
-12.85%
6-Month Change
-17.12%
Year-to-Date (YTD) Change
-20.24%
1-Year Change
-18.22%
3-Year Change
-17.23%
5-Year Change
-20.08%
All-Time (Max) Change
1807.07%

Contact Information

31 77 355 6600
Hulsterweg 82, Venlo, NaN, 5912 PL

Company Facts

5,700 Employees
IPO DateJun 28, 1996
CountryUS
Actively Trading

Frequently Asked Questions